Monoclonal antibodies, fusion proteins including the immunoglobulin fragment c (Ig Fc) CH2-CH3 domains, and engineered antibodies are prominent representatives of an important class of drugs and drug candidates, which are referred to as biotherapeutics or biopharmaceuticals. These recombinant proteins are highly heterogeneous due to their glycosylation pattern. In addition, enzyme-independent reactions, like deamidation, dehydration, and oxidation of sensitive side chains, may contribute to their heterogeneity in a minor amount. To investigate the biological impact of a spontaneous chemical modification, especially if found to be recurrent in a biotherapeutic, it would be necessary to reproduce it in a homogeneous manner. Herein, we undertook an explorative study towards the chemical synthesis of the IgG1 Fc CH3 domain, which has been shown to undergo spontaneous changes like succinimide formation and methionine oxidation. We used Fmoc-solid-phase peptide synthesis (SPPS) and native chemical ligation (NCL) to test the accessibility of large fragments of the IgG1 Fc CH3 domain. In general, the incorporation of pseudoproline dipeptides improved the quality of the crude peptide precursors; however, sequences larger than 44 residues could not be achieved by standard stepwise elongation with Fmoc-SPPS. In contrast, the application of NCL with cysteine residues, which were either native or introduced ad hoc, The analytical and biological characterization of mAbs and, in general, of large biomolecules is a challenging but indispensable task.
Indeed, the quality of a protein-based drug may be affected by the existence of multiple variants displaying altered biophysical and biochemical properties; such chemical diversity mainly arises from posttranslational modifications (PTMs), like glycosylation, and spontaneous degradation during the production and formulation processes. 8, 9 To this regard, the most commonly encountered enzyme-independent modifications are methionine oxidation, [10] [11] [12] deamidation of asparagine coupled to succinimide (Snn), aspartate and isoaspartate (isoAsp) formation, [13] [14] [15] [16] N-terminal glutamate or glutamine cyclization to pyroglutamate, [17] [18] [19] and arginine glycation or carbonylation. 20, 21 Spontaneous degradation products due to pyroglutamate formation, methionine oxidation, and asparagine deamidation have been observed in therapeutic mAbs. 22 In particular, the IgG1 Fc domain contains two conserved and solvent-exposed methionines at positions 432 in the CH3 domain ( Figure 1 ) and 256 in the CH2 domain, which have been shown to be susceptible to oxidation upon manufacturing and storage. 11 Moreover, it has been demonstrated by surface plasmon resonance that oxidation of Met-432 and Met-256 impacts the binding affinity to the human neonatal Fc receptor (FcRn), 23 protein A, and protein G, 24 which has been attributed to the alteration of the secondary structure surrounding the residues involved in the binding. 25 Asparagine deamidation and related products (Asp, isoAsp, and Snn)
have been detected in both the Fc and Fab regions of mAbs, causing alterations of their secondary structure, potency, and binding affinity, especially when occurring across the flexible complementarity-determining region, [26] [27] [28] thus having direct consequences on the Ab-mediated immune response. In the IgG1 Fc region, such PTM has been reported at Asn-319 within the sequence Leu-Asn-Gly-Lys in the CH2 domain, as well as at Asn-388, Asn-393, and Asn-438 within the CH3 domain [29] [30] [31] ( Figure 1 ). The biological impact of deamidation has been studied in the Fab region of mAbs, [26] [27] [28] whereas its effect on the Fc region remains to date unclear. However, the results of an alanine-scan on human IgG1 have revealed that replacement of Asn-438 influences the binding affinity for FcRn. 32 Therefore, also the structural change caused by deamidation at Asn-438 might potentially affect the FcRn binding.
Thus, oxidation and deamidation events may be considered two of the most important sources of enzyme-independent PTMs in drugs based on mAbs and Fc-fusion proteins. Moreover, both changes may influence the Ig binding to FcRn, thus affecting the half-life of Igs and Fc-fusion proteins in the blood. [33] [34] [35] Although spontaneous PTMs are fortunately present only as minimal impurities, which may be hardly detectable even by highly sophisticated MS analysis, 36, 37 nevertheless, the assessment of their structural and biological effects is of high significance. For this reason, it is often necessary to treat the protein chemically, in order to induce and investigate the desired PTM. For example, H 2 O 2 treatments are usually performed to increase the amount of oxidized methionine. This, however, results in multiple combinations of reduced and oxidized methionine residues. 11, 23, 38 In contrast, chemical protein synthesis (CPS) based on the native chemical ligation (NCL) of synthetic fragment precursors would, in principle, allow obtaining only one species at the time by replacing only the desired methionine with methionine sulfoxide. CPS has been successfully applied for small and medium-size proteins, [39] [40] [41] [42] [43] whereas other approaches have been developed to overcome the protein-size limitation, which rely on the NCL between synthetic and recombinant fragment precursors (socalled expressed protein ligation [44] [45] [46] ), or on the incorporation of unnatural amino acids (AAs) into a protein by genetic-code expansion. [47] [48] [49] At the light of the important role played by the CH3 domain in the binding of IgG molecules to FcRn 50,51 as well as in the dimerization process of minibodies, 4 we undertook the present work to assess the accessibility of this domain by chemical synthesis, which, in turn, would make variants containing, for example, oxidized methionine or D-amino acids at the desired position also accessible. In particular, we focused on the preparation of IgG1 CH3 fragment precursors for two possible NCL strategies that rely on threonine-based 52, 53 and cysteine-based 43, 54 chemoselective reactions (Scheme 1). The C-terminal fragment precursor (either 1, 4, or 6) contains oxidized methionine at position 432.
Problems encountered during the solid-phase peptide synthesis (SPPS) of the precursors and some solutions to them, as well as NCL attempts, are discussed below. Although the total chemical synthesis of the IgG1
Fc CH3 domain could not be achieved in this work, the conducted explorative study provides useful insights into the Fmoc-based SPPS of IgG1 Fc CH3 sequences, including C-terminally activated intermediates bearing the salicyladehyde ester (Sal) or a thioester.
| MATERIALS AND METHODS

| Chemicals
All protected AAs, Fmoc-Rink amide MBHA resin, N-(9-fluoreny- 
| Methods
Analytical RP-HPLC was performed using a Thermo Fisher Scientific Dionex UltiMate 3000 UHPLC system (Germering, Germany) and either a Syncronics C-18 column (100 Å, 5 μm, 250 × 4.6 mm, Thermo
Fisher Scientific) at a flow rate of 1.5 mL/min or a Nucleosil C-18 column (100 Å, 5 μm, 250 × 4 mm, Macherey-Nagel, Düren, Germany) at a flow rate of 1 mL/min. Unless specifically stated, the first one was used. The UV detection was set at 220 nm. The elution system was by using α-cyano-4-hydroxycinnamic acid as matrix. In Then, we envisioned a third route that contemplates the Cys-thioester ligation of four fragments, the largest one containing 38 residues (7), at two fast-reacting (Gly-389 and Phe-427) and one slow-reacting (Thr-370) C-terminal thioester (Scheme 1C). This, however, requires the temporary replacement of two native residues, Gln-390
and Ser-428, with Cys, and the reconversion of the two non-native residues to the native ones with suitable methods (see section 3.7). 
Considering the presence of quite regularly distributed Thr and
Ser residues in the sequence, we envisioned the possibility to increase the homogeneity of fragment 1 by incorporation of pseudoproline dipeptides, which are well known to reduce the on-resin self-association propensity of the growing peptide and, consequently, to improve the quality of the crude product. [59] [60] [61] Accordingly, by using the combination of a polar and low-loaded resin with the employment of the pseudoproline dipeptides Leu-445-ψSer-446, Phe-427-ψSer-428, and
Tyr-411-ψSer-412, the growing chain was~60% homogeneous after 44 couplings (1a TGT+ψ in Scheme 2B). Nevertheless, despite this encouraging result, the attempt to elongate this fragment with additional nine residues to obtain the desired precursor 1 failed (data not shown).
| Synthesis of [Met(O)-432]-IgG1-Fc 398-450 (1) by chemoselective ligation
Given the difficulties encountered in the standard stepwise Fmoc-SPPS of the fragment precursor 1, we considered the chemoselective ligation approach to accomplish the 53-residue long fragment by using the natural Cys-429 as ligation point between the two fragments 1b pling protocol. After the assembly was completed, we attempted to convert the Dbz group into the Nbz group. However, the conversion was incomplete, probably due to the sterically hindered C-terminal Thr(tBu)-370. Thus, we decided to cleave the peptide from the resin in the Dbz form 3a, which is more stable than the Nbz form 3 but may be orthogonally converted into a benzotriazole moiety with NaNO 2 and then displaced by the thiol additive in the ligation buffer to afford the peptide thioester in situ. 73 The TFA-cleaved product 3a
showed satisfactory homogeneity (~60%) (Scheme 5). However, this requires the presence of cysteine residues at suitable ligation sites, which is not the case for the native Cys-371
and Cys-429 (see Scheme 3 for ligation at Cys-429: although the ligation product was quickly built, concurrent side-reactions leading to thioester degradation were also fast). Therefore, Ser-428 and
Gln-390 were substituted with cysteine, in order to exploit highly ligation-favourable sites at Phe-427 and Gly-389 42 and also to have the possibility to achieve the assembly of the native IgG1 CH3 domain in the future (Scheme 1C Then, we proceeded with the ligation of the three peptides, starting with 6 and 7a that were mixed together in phosphate buffer (pH 7) containing 6 M GuHCl (Scheme 8A). MPAA was added for in situ conversion of the N-acyl-Nbz moiety into an aryl thioester. After 2-hour reaction, methoxylamine was added at pH 4 and left react for 6 hours to convert the N-terminal thiazolidine into cysteine and deliver peptide 9. Some impurities were present, which arose from However, optimization of the protocol for the stepwise Fmoc-SPPS might still be possible by the application of polyethylene glycol resins like ChemMatrix, 75 backbone-amide protecting groups like Dmb (dimethoxybenzyl) 76, 77 and Hmb (hydroxymethoxybenzyl), 78 or the O-acyl isopeptide method. [79] [80] [81] [82] [83] Moreover, heat-assisted SPPS has been recently very successful in the synthesis of very difficult sequences.
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We did not investigate the accessibility of the N-terminal fragment 345 to 397 by stepwise elongation, but rather prepared the two shorter fragments 2 and 3. Unfortunately, the Sal-activated peptide 2 was poorly soluble in the ligation solvent (pyridine/AcOH).
Thus, the assembly route to obtain the IgG1 Fc CH3 sequence was redesigned on the base of only Cys-based NCL. To test the feasibility of this route, besides using the native Cys-371, we decided to incorporate two non-native Cys residues in place of Ser-428 and Gln- Nbz on a peptide bearing a C-terminal leucine. 63 Unfortunately, in our case, the use of DMF did not solve the problem, and no Nbz peptide was formed (probably, because of the presence of the β-branched threonine). Thus, we activated the Dbz peptide 3a by converting it into an N-acyl-benzotriazole peptide by using NaNO 2 at pH~3, as previously shown by Liu and coworkers. 73 For the Acm cleavage from the C-terminal free acid of 8, we used the Pd-catalyzed reaction reported by Brik and coworkers. 92 Both reactions were successful, but, unfortunately, no ligation product was detected after 18-hour reaction. We did not try to change further the protocol, as the slow ligation rate of the C-terminal threonine is likely to prevent an efficient
synthesis. An alternative would be to move the third ligation site between Gly-375 and Phe-376, which would be advantageous for the preparation of the C-terminal Nbz peptide precursor as well as for the ligation rate. However, β-mercapto-Phe must be used, whose synthesis and use in NCL have been previously reported. 93 Another way would be the stepwise synthesis of the segment 345 to 389, which would avoid a third ligation.
In conclusion, this explorative study has shed light on the behaviour of different fragments of the IgG1 Fc CH3 domain during the standard Fmoc-SPPS as well as NCL, which will be useful to plan future syntheses. Once completed the CPS of the CH3 domain, it will be necessary to test, if the synthetic bis(cysteinyl)-polypeptide chain can undergo oxidative folding and build the expected noncovalent homodimer. 
